Literature DB >> 17574775

[Severe maternal morbidity].

S Ben Hamouda1, H Khoudayer, H Ben Zina, A Masmoudi, B Bouguerra, R Sfar.   

Abstract

OBJECTIVES: Severe maternal morbidity remains a public health issue in developing countries. We report in this retrospective study, patients' characteristics and frequency of pathologies responsible of severe maternal morbidity.
MATERIALS AND METHODS: Between January 1999 and December 2003, 119 cases of severe maternal pathologies of pregnancy and delivery occurred among 19,736 live births.
RESULTS: Severe maternal morbidity was 602.95 per 100,000 live births and obstetrical haemorrhages were the most frequent cause (39%) followed by hypertensive disease (25%). Maternal mortality rate was 30.4 per 100,000 live births, and hypertensive disease represents the first cause of mortality in our study, contrary to all Tunisian data where haemorrhage remains the first one.
CONCLUSION: Improvement of prognostic of high risk pregnancies has allowed diminution of maternal mortality. Instead of this diminution, efforts must be done in the management of severe obstetrical pathologies responsible of high maternal morbidity notably complications of hypertensive disease.

Entities:  

Mesh:

Year:  2007        PMID: 17574775     DOI: 10.1016/j.jgyn.2007.05.006

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  3 in total

1.  Pregnancy-related acute kidney injury: experience of the nephrology unit at the university hospital of fez, morocco.

Authors:  Mohamed Arrayhani; Randa El Youbi; Tarik Sqalli
Journal:  ISRN Nephrol       Date:  2012-12-20

2.  Embedding surveillance into clinical care to detect serious adverse events in pregnancy.

Authors:  Anna C Seale; Hellen C Barsosio; Angela C Koech; James A Berkley
Journal:  Vaccine       Date:  2015-08-05       Impact factor: 3.641

3.  Incidence of maternal peripartum infection: A systematic review and meta-analysis.

Authors:  Susannah L Woodd; Ana Montoya; Maria Barreix; Li Pi; Clara Calvert; Andrea M Rehman; Doris Chou; Oona M R Campbell
Journal:  PLoS Med       Date:  2019-12-10       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.